Role of Lipopolysaccharide, Derived from Various Bacterial Species, in Pulpitis-A Systematic Review

Biomolecules. 2022 Jan 15;12(1):138. doi: 10.3390/biom12010138.

Abstract

Lipopolysaccharide (LPS) is widely used for induction of inflammation in various human tissues, including dental pulp. The purpose of this study was to summarize current medical literature focusing on (1) cell types used by researchers to simulate dental pulp inflammation, (2) LPS variants utilized in experimental settings and how these choices affect the findings. Our study was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). We searched for studies reporting outcomes of lipopolysaccharide application on dental pulp cells in vitro using electronic databases: MEDLINE, Web of Science and Scopus. Having gathered data from 115 papers, we aimed to present all known effects LPS has on different cell types present in dental pulp. We focused on specific receptors and particles that are involved in molecular pathways. Our review provides an essential foundation for further research using in vitro models of pulpitis.

Keywords: LPS; inflammation; pulp cells; pulpitis.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Humans
  • Inflammation / metabolism
  • Lipopolysaccharides* / pharmacology
  • Pulpitis* / metabolism

Substances

  • Lipopolysaccharides